Inflammation in Focus: Does Variation in C-Reactive Protein Predict Coronary Calcification After Breast Radiotherapy?

JACC CardioOncol. 2025 Jun;7(4):445-447. doi: 10.1016/j.jaccao.2025.05.001.

¹ Radiation Epidemiology Team, Unit 1018 Centre for Research in Epidemiology and Population Health (CESP), National Institute for Medical Research (Inserm), Villejuif, France; Gustave Roussy Institute, Villejuif, France; Paris Saclay University, Gif-sur-Yvette, France.
² Department of Radiation Oncology (Orion), Clinique Pasteur, Toulouse, France.
³ UMR 1295 (CERPOP), National Institute for Medical Research (Inserm), Toulouse, France; Department of Cardiology, Rangueil University Hospital, Toulouse, France.
⁴ PSE-SANTE/SERAMED/LRMed Laboratory of Radiobiology of Medical Exposures, Authority for Nuclear Safety and Radiation Protection (ASNR), Fontenay-Aux-Roses, France.
⁵ Department of Radiology (GRX), Clinique Pasteur, Toulouse, France.
⁶ PSE-SANTE/SDOS Department of Dosimetry, Authority for Nuclear Safety and Radiation Protection (ASNR), Fontenay-Aux-Roses, France.
⁷ PSE-SANTE/SESANE/LEPID Laboratory of Epidemiology, Authority for Nuclear Safety and Radiation Protection (ASNR), Fontenay-Aux-Roses, France. Electronic address: sophie.jacob@asnr.fr.

No abstract available

Keywords: breast cancer; cancer survivorship; coronary artery disease; inflammatory biomarkers; radiation therapy; risk prediction.